Cargando…
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
OBJECTIVE: To describe the symptoms and clinical course of SARS-CoV-2 infection in patients with cystic fibrosis (CF). METHODS: We carried out a prospective multicentre cohort study based on 32 CF centres and 6597 patients. Centres were contacted to collect baseline and follow-up data of patients wh...
Autores principales: | Colombo, Carla, Alicandro, Gianfranco, Daccó, Valeria, Gagliano, Vanessa, Morlacchi, Letizia Corinna, Casciaro, Rosaria, Pisi, Giovanna, Francalanci, Michela, Badolato, Raffaele, Bignamini, Elisabetta, Messore, Barbara, Lucanto, Maria Cristina, Leonetti, Giuseppina, Maschio, Massimo, Cipolli, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118547/ https://www.ncbi.nlm.nih.gov/pubmed/33984027 http://dx.doi.org/10.1371/journal.pone.0251527 |
Ejemplares similares
-
P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021) -
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021) -
ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022) -
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022) -
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)